These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 11526166

  • 21. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
    White TC, Pfaller MA, Rinaldi MG, Smith J, Redding SW.
    Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
    [Abstract] [Full Text] [Related]

  • 22. [Correlation between resistance testing and typing of Candida albicans--isolates from AIDS patients and chronic recurrent oral candidiasis].
    Ruhnke M, Tennagen I, Engelmann E.
    Mycoses; 1994 May; 37 Suppl 1():60-3. PubMed ID: 7854368
    [Abstract] [Full Text] [Related]

  • 23. Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode.
    Vargas K, Messer SA, Pfaller M, Lockhart SR, Stapleton JT, Hellstein J, Soll DR.
    J Clin Microbiol; 2000 Oct; 38(10):3595-607. PubMed ID: 11015370
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
    Barchiesi F, Colombo AL, McGough DA, Fothergill AW, Rinaldi MG.
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2553-6. PubMed ID: 7872746
    [Abstract] [Full Text] [Related]

  • 25. Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting.
    Boerlin P, Boerlin-Petzold F, Goudet J, Durussel C, Pagani JL, Chave JP, Bille J.
    J Clin Microbiol; 1996 May; 34(5):1235-48. PubMed ID: 8727910
    [Abstract] [Full Text] [Related]

  • 26. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection.
    Redding SW, Pfaller MA, Messer SA, Smith JA, Prows J, Bradley LL, Fothergill AW, Rinaldi MG.
    J Clin Microbiol; 1997 Jul; 35(7):1761-5. PubMed ID: 9196188
    [Abstract] [Full Text] [Related]

  • 27. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
    Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M.
    J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530
    [Abstract] [Full Text] [Related]

  • 28. Sequences type analysis of Candida albicans isolates from Iranian human immunodeficiency virus infected patients with oral candidiasis.
    Katiraee F, Khalaj V, Khosravi AR, Hajiabdolbaghi M.
    Acta Med Iran; 2014 Sep; 52(3):187-91. PubMed ID: 24901719
    [Abstract] [Full Text] [Related]

  • 29. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
    Salari S, Khosravi AR, Mousavi SA, Nikbakht-Brojeni GH.
    J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
    [Abstract] [Full Text] [Related]

  • 30. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S, Santos ALS, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S.
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of internal transcribed spacer region of ribosomal DNA sequence analysis for molecular characterization of Candida albicans and Candida dubliniensis isolates from HIV-infected patients.
    Millon L, Piarroux R, Drobacheff C, Monod M, Grenouillet F, Bulle B, Bole J, Blancard A, Meillet D.
    Med Mycol; 2002 Dec; 40(6):535-43. PubMed ID: 12521117
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [Abstract] [Full Text] [Related]

  • 34. Biotypes of oral Candida albicans isolated from AIDS patients and HIV-free subjects in Thailand.
    Teanpaisan R, Nittayananta W, Chongsuvivatwong V.
    J Oral Pathol Med; 2000 May; 29(5):193-9. PubMed ID: 10801035
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The in vitro lysozyme susceptibility of Candida albicans cultured in carbohydrate-supplemented media.
    Samaranayake YH, MacFarlane TW, Aitchison TC, Samaranayake LP.
    Oral Microbiol Immunol; 1993 Jun; 8(3):177-81. PubMed ID: 8233572
    [Abstract] [Full Text] [Related]

  • 37. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
    Jiang L, Yong X, Li R, Peng Y, Liu W, Qin Q, Zhang L, Liu Z, Liang H, Tao R.
    J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Candida dubliniensis identification in Brazilian yeast stock collection.
    Mariano Pde L, Milan EP, da Matta DA, Colombo AL.
    Mem Inst Oswaldo Cruz; 2003 Jun; 98(4):533-8. PubMed ID: 12937769
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.